论文信息 - Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.

Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.

To assess the possible modulatory effects of insulin-like growth factor-1 (IGF-1) on the brain effects of proinflammatory cytokines, male CD-1 mice were injected into the lateral ventricle of the brain with a behaviorally depressing dose (100 ng) of the cytokine inducer lipopolysaccharide (LPS) and their response to various doses of IGF-1 (0, 100 and 1000 ng) was measured during behavioral tests carried before and at various time intervals after treatment. LPS induced a profound behavioral depression that was abrogated by the higher dose of IGF-1 tested. Since the behavioral effects of LPS are mediated by the local synthesis and results of proinflammatory cytokines, these results indicate that IGF-1 interferes with the production and/or action of proinflammatory cytokines in the brain.

R. Dantzer | G. Gheusi | K. Kelley | R. Johnson | R. Johnson

[1] N. Brindle,et al. Regulation of Insulin-Like Growth Factor-1 Expression in Vascular Endothelial Cells by the Inflammatory Cytokine Interleukin-1 , 1998, Journal of Vascular Research.

[2] S. Doré,et al. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. , 1997, Trends in neurosciences.

[3] N. Rothwell,et al. Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[4] X. Liu,et al. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis , 1995, Multiple sclerosis.

[5] C. Z. Zhu,et al. Intraventricular Administration of Insulin and IGF-1 in Transient Forebrain Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.